Hepatitis B and C testing: people at risk of infection

1 Case finding

How can case-finding for hepatitis B and C be improved? What modifiable factors influence whether or not specific groups at increased risk of hepatitis B and hepatitis C infection are identified and tested?

2 Treatment uptake

How can the uptake of hepatitis C treatment be improved? What factors influence whether or not specific groups at increased risk will begin and complete hepatitis C treatment?

3 Case finding among migrant populations

What cost-effective interventions can be used to increase hepatitis B case-finding among migrant populations in primary and secondary care?

4 Continuity of care for prisoners

What cost-effective interventions ensure continuity of care for prisoners who are diagnosed with chronic hepatitis B or C in prison?

5 Alternate testing sites

How cost effective are alternative testing sites, such as community pharmacist programmes, for increasing the number of people who are tested and treated for hepatitis B and C?

6 Involving groups at increased risk in awareness-raising

What are the most effective ways of involving people from groups at increased risk in awareness-raising about, and promoting testing and treatment for, hepatitis B and C infection? Specifically, how cost effective are peer mentor programmes at increasing the number of people at increased risk who are tested and treated for hepatitis B and C?

7 Impact of increased knowledge and awareness

What impact does increased knowledge and awareness of hepatitis B and C among the general public have on the uptake of testing and treatment?

8 Interventions for other communicable diseases

Which interventions for other communicable diseases could be used to encourage people at increased risk of hepatitis B and C infection to take up the offer of testing and treatment?

9 Chronic hepatitis B and C among children

How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

10 Chronic hepatitis B and C incidence

How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

11 Cohort testing programmes

How cost effective are cohort testing programmes:

See appendix D for detail on the gaps in the evidence identified during development of this guidance.